Metformin-Induced Eosinophilic Interstitial Lung Disease

Metformin, a mainstay treatment for type two diabetes mellitus has several side effects, ranging from mild to life-threatening ones. One report has found the combination of metformin/glibenclamide a culprit for interstitial lung disease. Other studies have shown that metformin has a protective effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Alyami, Sami M, Alrasheed, Sarah K, Albogami, Bashayer A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228833/
https://www.ncbi.nlm.nih.gov/pubmed/37261145
http://dx.doi.org/10.7759/cureus.38339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228833/
https://www.ncbi.nlm.nih.gov/pubmed/37261145
http://dx.doi.org/10.7759/cureus.38339

Ejemplares similares